4 Merger and Acquisitions Stock Stories Ready for a Midweek Appraisal

Apple Inc. (NASDAQ:AAPL): Current price $493.65

Apple has acquired the Swedish startup AlgoTrim, which builds codecs and designs solutions that optimize performance of mobile imaging, data, video, and computer graphics while minimizing memory requirements, said a new report by the Swedish emerging industry news service Rapidus, confirmed separately by TechCrunch. The purchase helps Apple by permitting it to build more efficient media deliver for mobile devices that use up less bandwidth while preserving quality.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

AAPL 20130828

Endo Health Solutions Inc. (NASDAQ:ENDP): Current price $40.49

On Wednesday, Endo announced that its Qualitest subsidiary will purchase the privately-held Boca Pharmacal, which is a specialty generics firm, at a cash price $225 million. The acquisition should enhance the growth platform and pipeline for Endo’s Qualitest business, and is in-line with Endo’s strategic transformation into a specialty healthcare firm. The deal should close before the end of the year, subject to the usual regulatory requirements. The purchase will be financed with Endo’s present cash on hand.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

ENDP 20130828

CEMEX SAB de CV (NYSE:CX): Current price $11.23

The Swiss cement maker Holcim will exchange some assets and combine others with its Mexican competitor Cemex in Europe, as it searches for cost savings in resaction to tough conditions in the construction sector. For its part, Holcim said that it might grow operating profit by up to 30 million euro, resulting from the arrangement.

The company will pay Cemex 70 million euro in cash, primarily reflecting the magnitude and value of Cemex’s German unit, which includes some 100 readymix and other plants. Holcim will purchase Cemex’s operations in western Germany while Cemex will take over Holcim’s operations in the Czech Republic. The parties will combine their operations in Spain with Holcim taking a 25-percent interest in the combined entity.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

CX 20130828

LeMaitre Vascular, Inc. (NASDAQ:LMAT): Current price $6.95

LeMaitre announced Wednesday that it has bought the assets of InaVein, LLC for $2.5 million, or 1.1 times InaVein’s 2012 sales, and potential earn-out payments in 2014 and 2015 based on the performance of the purchased business and regulatory approval in China. InaVein owned and marketed the TRIVEX System, which carried a gross margin of between 60 and 70 percent. LaMaitre provides peripheral vascular devices and implants.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

LMAT 20130828

Don’t Miss: Why Is This Nonprofit Trying to Put Sirius XM in the Penalty Box?

More Articles About:    

More from The Cheat Sheet